ONCOLOGY

Konstantin Gordon et.al. presented a case of a 30-year-old woman with a medical history as well as surgery followed by conventional radiotherapy and chemotherapy, and two times stereotactic RT (in…

A team of investigators in their initial studies have mentioned that clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–…

New data suggests that COVID vaccines do not work well for patients with hematologic malignancies.  "Clinicians caring for patients with hematological malignancies and other immunocompromsing…

A medical tribunal reported that leading oncologist Professor Justin Stebbing gave chemotherapy to a patient in the "over-optimistic" belief he could reverse her advanced and aggressive lung…

Adam B. Murphy et.al. conducted a study to assess the impact on treatment choice in high-risk populations of African Americans, with respect to patient selection for active surveillance in cases…

Jason J. Zoeller et.al. conducted a study to evaluate the effectiveness of two EGFR-targeted antibody-drug conjugates (ADC: ABT-414; ABBV-321) in combination with navitoclax, an antagonist of the…

The European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion of the product; approval across the European Union usually follows. Duvelisib is already on…

In an analysis of claims data from January 2009 to March 2020, the bisphosphonate alendronate represented more than 50% of all prescriptions for bone-directed therapies, but growth in the use of…